BIOMAT Database Logo BIOMAT Database Logo

[Voltaren in the treatment of rheumatic diseases]. 1977

E S Tsvetkova, and T M Trofimova

UI MeSH Term Description Entries
D008297 Male Males
D010648 Phenylacetates Derivatives of phenylacetic acid. Included under this heading are a variety of acid forms, salts, esters, and amides that contain the benzeneacetic acid structure. Note that this class of compounds should not be confused with derivatives of phenyl acetate, which contain the PHENOL ester of ACETIC ACID. Benzeneacetates,Benzeneacetic Acids,Phenylacetic Acids,Acids, Benzeneacetic,Acids, Phenylacetic
D004008 Diclofenac A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt. Diclophenac,Dichlofenal,Diclofenac Potassium,Diclofenac Sodium,Diclonate P,Dicrofenac,Feloran,GP-45,840,Novapirina,Orthofen,Orthophen,Ortofen,SR-38,Sodium Diclofenac,Voltaren,Voltarol,Diclofenac, Sodium,GP 45,840,GP45,840,SR 38,SR38
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D012216 Rheumatic Diseases Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement. Rheumatism,Disease, Rheumatic,Diseases, Rheumatic,Rheumatic Disease

Related Publications

E S Tsvetkova, and T M Trofimova
[Voltaren in the treatment of rheumatic diseases].
January 1978, Vojnosanitetski pregled,
E S Tsvetkova, and T M Trofimova
[Effectiveness of Voltaren and Brufen in rheumatic diseases].
January 1975, Reumatizam,
E S Tsvetkova, and T M Trofimova
[Experiences with the use of sodium diclofenac (Voltaren) in rheumatic diseases].
February 1978, Minerva medica,
E S Tsvetkova, and T M Trofimova
[Clinical experiences and results of clinical experimental studies with Voltaren in rheumatic diseases].
March 1976, Wiener medizinische Wochenschrift (1946),
E S Tsvetkova, and T M Trofimova
[Diclofenac (Voltaren) - post-marketing evaluation. An open study on patients with rheumatic diseases].
April 1981, Ugeskrift for laeger,
E S Tsvetkova, and T M Trofimova
[The use of Voltaren for the rehabilitation of rheumatic conditions (author's transl)].
January 1978, Journal belge de medecine physique et de rehabilitation. = Belgisch tijdschrift voor fysische geneeskunde en rehabilitatie,
E S Tsvetkova, and T M Trofimova
Voltaren in the treatment of rheumatoid arthritis.
May 1974, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
E S Tsvetkova, and T M Trofimova
[Treatment of rheumatic diseases].
October 1954, Deutsches medizinisches Journal,
E S Tsvetkova, and T M Trofimova
Treatment of rheumatic diseases.
January 1987, British medical journal (Clinical research ed.),
E S Tsvetkova, and T M Trofimova
[Ultrasonics in the treatment of rheumatic diseases].
July 1954, Revista clinica espanola,
Copied contents to your clipboard!